Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 48
Filtrar
1.
Int J Obes (Lond) ; 42(4): 711-720, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29104286

RESUMEN

BACKGROUND/OBJECTIVES: Obesity (body mass index (BMI)⩾30 kg m-2) is associated with an increased risk of estrogen-dependent breast cancer after menopause. Levels of aromatase, the rate-limiting enzyme in estrogen biosynthesis, are elevated in breast tissue of obese women. Recently, the regulation of aromatase by the p53-hypoxia-inducible factor-1α (HIF1α)/pyruvate kinase M2 (PKM2) axis was characterized in adipose stromal cells (ASCs) of women with Li-Fraumeni Syndrome, a hereditary cancer syndrome that predisposes to estrogen-dependent breast cancer. The current study aimed to determine whether stimulation of aromatase by obesity-associated adipokine leptin involves the regulation of the p53-HIF1α/PKM2 axis. SUBJECTS/METHODS: Human breast ASCs were used to characterize the p53-HIF1α/PKM2-aromatase axis in response to leptin. The effect of pharmacological or genetic modulation of protein kinase C (PKC), mitogen-activated protein kinase (MAPK), p53, Aha1, Hsp90, HIF1α and PKM2 on aromatase promoter activity, expression and enzyme activity was examined. Semiquantitative immunofluorescence and confocal imaging were used to assess ASC-specific protein expression in formalin-fixed paraffin-embedded tissue sections of breast of women and mammary tissue of mice following a low-fat (LF) or high-fat (HF) diet for 17 weeks. RESULTS: Leptin-mediated induction of aromatase was dependent on PKC/MAPK signaling and the suppression of p53. This, in turn, was associated with an increase in Aha1 protein expression, activation of Hsp90 and the stabilization of HIF1α and PKM2, known stimulators of aromatase expression. Consistent with these findings, ASC-specific immunoreactivity for p53 was inversely associated with BMI in breast tissue, while HIF1α, PKM2 and aromatase were positively correlated with BMI. In mice, HF feeding was associated with significantly lower p53 ASC-specific immunoreactivity compared with LF feeding, while immunoreactivity for HIF1α, PKM2 and aromatase were significantly higher. CONCLUSIONS: Overall, findings demonstrate a novel mechanism for the obesity-associated increase in aromatase in ASCs of the breast and support the study of lifestyle interventions, including weight management, which may reduce breast cancer risk via effects on this pathway.


Asunto(s)
Aromatasa/metabolismo , Neoplasias de la Mama/metabolismo , Leptina/metabolismo , Obesidad/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Adipocitos/metabolismo , Animales , Aromatasa/genética , Índice de Masa Corporal , Mama/citología , Mama/metabolismo , Proteínas Portadoras/metabolismo , Células Cultivadas , Femenino , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Glándulas Mamarias Animales/metabolismo , Proteínas de la Membrana/metabolismo , Ratones , Transducción de Señal , Hormonas Tiroideas/metabolismo , Proteínas de Unión a Hormona Tiroide
2.
Genes Brain Behav ; 17(1): 36-48, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-28589689

RESUMEN

Early experiences can have enduring impacts on brain and behavior, but the strength of these effects can be influenced by genetic variation. In principle, polymorphic CpGs (polyCpGs) may contribute to gene-by-environment interactions (G × E) by altering DNA methylation. In this study, we investigate the influence of polyCpGs on the development of vasopressin receptor 1a abundance in the retrosplenial cortex (RSC-V1aR) of prairie voles (Microtus ochrogaster). Two alternative alleles ('HI'/'LO') predict RSC avpr1a expression, V1aR abundance and sexual fidelity in adulthood; these alleles differ in the frequency of CpG sites and in methylation at a putative intron enhancer. We hypothesized that the elevated CpG abundance in the LO allele would make homozygous LO/LO voles more sensitive to developmental perturbations. We found that genotype differences in RSC-V1aR abundance emerged early in ontogeny and were accompanied by differences in methylation of the putative enhancer. As predicted, postnatal treatment with an oxytocin receptor antagonist (OTA) reduced RSC-V1aR abundance in LO/LO adults but not their HI/HI siblings. Similarly, methylation inhibition by zebularine increased RSC-V1aR in LO/LO adults, but not in HI/HI siblings. These data show a gene-by-environment interaction in RSC-V1aR. Surprisingly, however, neither OTA nor zebularine altered adult methylation of the intronic enhancer, suggesting that differences in sensitivity could not be explained by CpG density at the enhancer alone. Methylated DNA immunoprecipiation-sequencing showed additional differentially methylated regions between HI/HI and LO/LO voles. Future research should examine the role of these regions and other regulatory elements in the ontogeny of RSC-V1aR and its developmentally induced changes.


Asunto(s)
Arvicolinae/genética , Receptores de Vasopresinas/genética , Alelos , Animales , Encéfalo/fisiología , Islas de CpG , Metilación de ADN , Femenino , Interacción Gen-Ambiente , Variación Genética , Genotipo , Masculino , Polimorfismo Genético , Conducta Sexual Animal/fisiología
3.
Chem Commun (Camb) ; 50(52): 6869-71, 2014 Jul 04.
Artículo en Inglés | MEDLINE | ID: mdl-24835343

RESUMEN

Four 2-(styryl)triphenylene derivatives (TSs) were synthesized for deep-blue dopant materials. By using a pyrene-containing compound, DMPPP, as the host, the TS-doped devices exhibited significant delayed fluorescence via triplet-triplet annihilation, providing the highest quantum efficiency of 10.2% and a current efficiency of 12.3 cd A(-1).

4.
Transplant Proc ; 46(3): 900-2, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24767376

RESUMEN

INTRODUCTION: The shortage of donor hearts for transplantation could be alleviated by including the hearts of older donors. Previous literature revealed similar early and medium-term survival outcomes compared with those of younger donors. This study presents our experience with patients who underwent orthotopic heart transplantation and concomitant coronary artery bypass grafting at our institution. METHODS: We present our experience with 11 patients with end-stage cardiomyopathy (8 men and 3 women) undergoing orthotopic heart transplantation and concomitant coronary artery bypass grafting from September 2002 to November 2011 at our institute. RESULTS: All 11 donor organs would otherwise have been rejected, depriving potential recipients of organ transplantation. Two patients received concurrent 2-coronary-artery bypass, and the other 9 patients received concurrent single-coronary-artery bypass during orthotopic heart transplantation. All patients had an uneventful postoperative course, with follow-up completed 3 to 128 months after cardiac transplantation and concomitant coronary artery bypass grafting surgery. CONCLUSIONS: Our experiences suggest that donor hearts requiring coronary artery bypass grafting, which form a small but significant donor subgroup, can be used effectively and safely when matched to the recipients' age and medical condition.


Asunto(s)
Puente de Arteria Coronaria , Trasplante de Corazón , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad
5.
J Viral Hepat ; 21(10): 706-15, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24304473

RESUMEN

Chronic kidney disease (CKD) is a worldwide health issue with heavy economic burden. Chronic hepatitis C virus (HCV) infection is a common cause of CKD, which can significantly impact the progression and mortality among patients with CKD. The prevalence of both illnesses is high in Taiwan. A multicentre and population-based cross-sectional study including 24 642 subjects was conducted to explore the association of HCV infection with the prevalence and severity of CKD. The measurements of metabolic parameters, eGFR and CKD stages were compared between subjects with HCV seropositivity and seronegativity. The analyses of association between HCV infection with CKD stages and evaluation of potential risk factors of CKD were performed by gender and age (≤ and >45 years). HCV-seropositive subjects accounted for 6.9% and had a significantly older age. The prevalence of CKD increased in those with HCV seropositivity (16.5%). Significantly higher prevalence of CKD stages ≥3 in HCV-seropositive subjects was noticed (7.8%). Age (>45 year), male gender, alcohol drinking, hypertension, creatinine and HCV infection were the significant factors associated with the presence of CKD. HCV seropositivity was an independent risk factor of developing CKD and associated with an increased risk of having CKD of all stages. The higher prevalence of earlier stage of CKD warrants longitudinal studies with frequent testing on renal function and sufficient duration to determine the changes of eGFR over time. Implementation of effective treatment intervention is also required for these subjects to prevent the progression of CKD to late stages.


Asunto(s)
Hepatitis C Crónica/complicaciones , Hepatitis C Crónica/patología , Insuficiencia Renal Crónica/complicaciones , Insuficiencia Renal Crónica/patología , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Creatinina/sangre , Estudios Transversales , Femenino , Tasa de Filtración Glomerular , Hepatitis C Crónica/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Proteinuria , Insuficiencia Renal Crónica/epidemiología , Índice de Severidad de la Enfermedad , Factores Sexuales , Taiwán/epidemiología
6.
Ann Oncol ; 24(2): 463-468, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23059959

RESUMEN

BACKGROUND: The purpose of this study is to characterize the risk factors of bloodstream infection (BSI) associated with the use of permanent implantable venous ports (Port-A) in solid cancer patients. METHODS: Solid cancer patients implanted with a Port-A were prospectively observed for the occurrence of Port-A-associated BSI (PABSI), defined as BSI without other identifiable infection foci. A PABSI risk score was developed using the Cox proportional hazards model. RESULTS: A total of 415 patients were registered; 88 PABSI episodes occurred in 58 patients (incidence1.05 per 1000 catheter-days). All but one patient had stage IV cancer. Independent predictors of PABSI occurrence included neutropenia, total parenteral nutrition (TPN), chronic steroid use, invasive procedures, postoperative antibiotics, and preoperative antibiotics. A PABSI risk score with a cut-off value of 0 (sensitivity 88.5%, specificity 64.3%) was defined for stage IV cancer patients as follows: neutropenia, +1.350; TPN, +1.256; chronic steroid use, +1.947; preoperative antibiotics, -0.970; postoperative antibiotics, +0.959; and invasive procedures, +1.098. The median PABSI-free survival was 4.47 months for patients with scores ≥ 0 but not reached for patients with scores <0 (P < 0.0001). CONCLUSION: The PABSI risk score can assist in identifying high-risk solid cancer patients and may assist in designing future preventive strategies.


Asunto(s)
Cateterismo Venoso Central/efectos adversos , Nutrición Parenteral Total/efectos adversos , Sepsis/mortalidad , Dispositivos de Acceso Vascular/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Estudios de Casos y Controles , Infección Hospitalaria/epidemiología , Infección Hospitalaria/prevención & control , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/tratamiento farmacológico , Neutropenia , Modelos de Riesgos Proporcionales , Riesgo , Sepsis/epidemiología , Sepsis/microbiología , Sobrevida , Adulto Joven
7.
Eur J Neurol ; 19(11): 1462-9, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22577844

RESUMEN

BACKGROUND AND PURPOSE: We recently reported a novel -62 G/A polymorphism within ataxin 8 (ATXN8) gene promoter region, with -62 G displaying significantly higher luciferase activity compared with -62 A. Phenotypic variability in spinocerebellar ataxia type 8 (SCA8) has been suggested, and large SCA8 repeats were found in patients with Parkinson's disease (PD). We aimed to investigate the association of ATXN8 -62 G/A polymorphism with the risk of Taiwanese PD, and identify the trans-acting factor modulating the ATXN8 promoter activity. METHODS: A case-control study in a cohort of 569 PD cases and 547 ethnically matched controls was conducted by polymerase chain reaction (PCR) and restriction enzyme analysis. The trans-acting factor binding to the ATXN8 promoter was examined by chromatin immunoprecipitation (ChIP)-PCR assay, cDNA co-transfection and luciferase reporter assay. RESULTS: When genotype distribution was calculated by comparing the rare AA genotype with the GG + GA genotypes (recessive model), a significant difference was found (P = 0.035, 1 df). Individuals carrying AA genotype exhibited a decreased risk of developing PD (odds ratio: 0.73; 95% CI: 0.55-0.98, P = 0.035). After stratification by age, individuals over 60 years of age carrying AA genotype demonstrated a further decrease in the risk of developing PD (odds ratio: 0.64; 95% CI: 0.43-0.96, P = 0.030). ChIP-PCR and cDNA over-expression revealed that CCAAT/enhancer-binding protein alpha binds to the ATXN8 proximal promoter to upregulate ATXN8 expression in neuroblastoma SK-N-SH cells. CONCLUSIONS: Our data suggest that ATXN8 -62 G/A polymorphism plays a role in Taiwanese PD susceptibility.


Asunto(s)
Predisposición Genética a la Enfermedad/genética , Proteínas del Tejido Nervioso/genética , Enfermedad de Parkinson/genética , Polimorfismo de Nucleótido Simple , Regiones Promotoras Genéticas/genética , Adulto , Anciano , Anciano de 80 o más Años , Western Blotting , Estudios de Casos y Controles , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa , Factores de Riesgo , Taiwán , Adulto Joven
8.
Transplant Proc ; 44(4): 886-9, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22564575

RESUMEN

BACKGROUND: To establish quicker cardiac arrest and less myocardial distension injury during heart procurement, we combined St. Thomas and histidine-tryptophan-ketoglutarate (HTK) solutions for donor heart preservation since June 2008. METHODS: From June 2008 to March 2010, we enrolled 31 heart transplantation (HT) patients in this study. During heart procurement we initially infused 1,000 mL cold St Thomas cardioplegic solution to achieve cardiac arrest. After procurement, a further 2,000 mL of cold HTK solution was infused at low perfusion pressure. Another 1,000 mL cold HTK solution was perfused before donor heart implantation. We examined donor age, recipient preoperative characteristics, ischemia time, hospital stay, postoperative graft function, major cardiac events, and transplant vasculopathy (TCAD). RESULTS: Twenty-two patients (71.0%) presented with dilated cardiomyopathy and 7 (23.3%) with ischemia cardiomyopathy. There were 23 (76.7%) male donors, and the mean donor age was 38.4 ± 13.8 years. Six patients underwent a redo sternotomy, 1 patient needed a third-do sternotomy, and 1 a seventh sternotomy (third HT) for repeated endocarditis and graft failure. The average ischemia time was 224.9 ± 71.0 minutes and the postoperative hospital stay was 57.7 ± 47.7 days. The surgical mortality (3.2%) was not accompanied by hospital or follow-up mortality. Patient left ventricular ejection fraction postoperative was 59.6 ± 2.3% with good functional status. Major cardiac events occurred in 8 patients (26.7%) without major complications. There were two subjects with TCAD but normal graft function. The correlation between ischemia time and hospital stay was insignificant (r = 0.21; P = .26). CONCLUSIONS: Donor heart preservation combining St Thomas cardioplegic arest and low-pressure perfusion with HTK solution seemed to be safe with. short-term survival similar to other approaches.


Asunto(s)
Cardiomiopatías/cirugía , Soluciones Cardiopléjicas/uso terapéutico , Paro Cardíaco Inducido/métodos , Trasplante de Corazón , Preservación de Órganos/métodos , Adolescente , Adulto , Factores de Edad , Bicarbonatos/efectos adversos , Bicarbonatos/uso terapéutico , Cloruro de Calcio/efectos adversos , Cloruro de Calcio/uso terapéutico , Cardiomiopatías/mortalidad , Soluciones Cardiopléjicas/efectos adversos , Isquemia Fría , Femenino , Glucosa/efectos adversos , Glucosa/uso terapéutico , Supervivencia de Injerto , Paro Cardíaco Inducido/efectos adversos , Paro Cardíaco Inducido/mortalidad , Trasplante de Corazón/efectos adversos , Trasplante de Corazón/mortalidad , Mortalidad Hospitalaria , Humanos , Tiempo de Internación , Magnesio/efectos adversos , Magnesio/uso terapéutico , Masculino , Manitol/efectos adversos , Manitol/uso terapéutico , Persona de Mediana Edad , Preservación de Órganos/efectos adversos , Preservación de Órganos/mortalidad , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/cirugía , Cloruro de Potasio/efectos adversos , Cloruro de Potasio/uso terapéutico , Procaína/efectos adversos , Procaína/uso terapéutico , Reoperación , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Cloruro de Sodio/efectos adversos , Cloruro de Sodio/uso terapéutico , Taiwán , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
9.
Transplant Proc ; 44(4): 1143-5, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22564648

RESUMEN

INTRODUCTION: In xenotransplantation, antibodies mediate humoral rejection, resulting in organ dysfunction. Removal of xenoantibodies is likely a first step for successful transplantation. Double filtration plasmapheresis (DFPP) selectively removes large molecular weight pathogenic substances, such as immunoglobulins (Ig), without other plasma proteins. The antibodies fractions removed and the changes in blood biochemistry are unanswered questions after DFPP in addressed this ex vivo swine heart perfusion model. MATERIALS AND METHODS: Twelve swine hearts were perfused with human blood in a modified Langendorff's apparatus. The perfusate containing human blood was divided into 2 groups: controls (N = 6) and DFPP-treated group (N = 4). Blood counts, biochemistry data, and immunological profiles were compared at 3 time points: before and after DFPP and after heart perfusion. RESULT: Perfusion times of control and DFPP groups were 5.43 ± 1.81 vs 9.25 ± 3.00 hours, respectively. Only the values of albumin and total protein showed difference. The immunologic profile revealved complete removal of IgM and most IgG, IgA, C3, and C4, namely, 79.95%, 88.58%, 83.15%, and 87.97%, respectively. CONCLUSION: DFPP showed excellent efficacy to remove xenoantiboidies and prolong xenograft survival in an ex vivo perfusion model.


Asunto(s)
Anticuerpos Heterófilos/sangre , Supervivencia de Injerto , Corazón , Inmunidad Humoral , Inmunoglobulina G/sangre , Perfusión , Plasmaféresis/métodos , Animales , Transfusión Sanguínea , Humanos , Modelos Animales , Albúmina Sérica/metabolismo , Porcinos , Factores de Tiempo , Trasplante Heterólogo/inmunología
10.
Transplant Proc ; 44(3): 817-9, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22483504

RESUMEN

OBJECTIVE: The mortality rate among patients with septic shock is high despite current therapy. We present a case of Fournier's gangrene and septic shock at 4 years post-heart transplantation that was reversed by "continuous enteral feeding" of the digestive enzyme inhibitor, gabexate mesilate. Recently, powerful pancreatic digestive proteases in the lumen of the intestine have been identified as initiators of the systemic inflammatory response. Intraluminal inhibitions of the proteases significantly attenuates intestinal damage, system inflammation, and multiorgan failure in experimental forms of shock but it has not been tested in man. METHODS AND RESULTS: Gabexate mesilate, a synthetic digestive protease inhibitor, was continuously administered in two liters of crystalloid solution to a patient by enteral feeding during septic shock. The condition and markers for shock due to sepsis reversed in a few days. CONCLUSION: This case suggested that "enteral" digestive protease inhibition may decrease and even reverse the sequelae of shock and sepsis.


Asunto(s)
Trasplante de Corazón , Inhibidores de Proteasas/uso terapéutico , Choque Séptico/tratamiento farmacológico , Adulto , Humanos , Persona de Mediana Edad , Inhibidores de Proteasas/administración & dosificación
11.
Breast Cancer Res Treat ; 130(1): 345-51, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21792625

RESUMEN

Metaplastic carcinoma of the breast (MCB) is a rare subtype of breast cancer. Anecdotal reports are available regarding its response to systemic chemotherapy. We reviewed the records of patients diagnosed with MCB at National Taiwan University Hospital between 1988 and 2009. A total of 46 MCB cases were identified from 8,695 breast tumor patients who underwent biopsy or resection. About 11 of 25 patients with initial bulky disease (T3-4) received neoadjuvant chemotherapy before surgery, and 2 (18.2%) exhibited a partial response. About 12 of 18 patients who developed distant metastasis received palliative systemic chemotherapy. Of them, only 1 (8.3%), 1 (10%), and none (0%) responded to first-, second-, or third- and beyond line chemotherapy, respectively. None of the patients who received anthracyline- (n = 13), vinorelbine- (n = 7), or cyclophosphamide-based (n = 18) chemotherapy responded, whereas 3 (17.6%) of 17 patients who received taxane-based chemotherapy exhibited a partial response. Tumor response to systemic chemotherapy remains generally poor for MCB patients. Taxanes may have modest activity, but need to be validated in further studies.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Carcinoma/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos/administración & dosificación , Neoplasias de la Mama/patología , Carcinoma/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante , Estadificación de Neoplasias , Cuidados Paliativos , Pronóstico , Resultado del Tratamiento
12.
Andrologia ; 42(4): 225-30, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20629644

RESUMEN

Varicocele-associated apoptosis has been recognised as a cause of male infertility. Thus, we assessed the expression of somatic apoptosis-related proteins (the typical protein-dependent apoptosis markers) in ejaculated sperm plasma from both patients with varicocele and normal donors. We evaluated the relationships between certain apoptosis-related proteins and normal semen quality. Semen samples were obtained from 25 patients with varicocele and from 10 normal fertile controls. These samples were compared using computer-assisted semen analysis for motion parameters and manual analysis for morphology, and were also assayed for apoptosis-related protein activation including caspase-3, poly-ACP-ribose polymerase (PARP), the Bcl-2 family (Bcl-2, Bak) and p53 by means of immunoblot analysis. PARP, Bak and p53 were expressed substantially more in the sperm cells of the varicocele group when compared with the normal group (P < 0.05). The expression of caspase-3 and Bcl-2 did not appear to differ between these two study groups. An increased expression of PARP, Bak and p53 for varicocele-afflicted individuals indicated an increased participation by these agents in the regulating of apoptosis in the ejaculated semen from patients with varicocele, suggesting that certain protein-development apoptotic mechanisms might originate in the cytoplasmic droplet or within mitochondria of spermatocytes and then might function within the nucleus of the cell.


Asunto(s)
Apoptosis/fisiología , Espermatozoides/metabolismo , Varicocele/fisiopatología , Adulto , Caspasa 3/biosíntesis , Eyaculación/fisiología , Expresión Génica , Humanos , Infertilidad Masculina/metabolismo , Masculino , Poli(ADP-Ribosa) Polimerasas/biosíntesis , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , Análisis de Semen , Proteína p53 Supresora de Tumor/biosíntesis , Proteína Destructora del Antagonista Homólogo bcl-2/biosíntesis
13.
J Clin Pharm Ther ; 34(5): 555-60, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19753680

RESUMEN

BACKGROUND AND OBJECTIVE: Insomnia is a common complaint in the general population. Interest in the use of alternative treatments for insomnia is increasing exponentially and is fairly common in Taiwan. We undertook a survey to define the drug utilization patterns of Chinese herbal medicines (CM) for insomnia in Taiwan. METHODS: The survey was conducted over a period of 4 years, from January 2003 to December 2006. Outpatients with primary insomnia and being treated with CM were studied. Core drug-use indicators were the number of CM items per prescription, the dosing frequency and duration of CM prescriptions, the most common prescribed CM herbs and CM formulae used. RESULTS: Six thousand eight hundred and sixty patients, using 37,046 CM herb items, were screened during the study period. The average CM items per prescription was 5.40. Most of prescriptions (95.23%) were prescribed for administration three times a day. The most often prescribed Chinese herbal products were Hong-Hwa (Carthamus tinctorius) and Jia-Wey-Shiau-Yau-San, which includes Angelica sinensis, Atractylodes macrocephala, Paeonia lactiflora, Bupleurum chinense, and Poria coco. CONCLUSION: This is the first extensive survey examining the drug utilization patterns of Chinese herbal medicines in the treatment of insomnia. Although the data were generated in Taiwan, the herbs and practices identified are likely to be widely generalizable wherever Chinese herbal remedies are used for insomnia. Multiple herbs and complex formulae were commonly used. The baseline data generated should be of use in informing subsequent studies, including those aimed at a thorough evaluation of the herbs' effectiveness.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Medicina Tradicional China , Trastornos del Inicio y del Mantenimiento del Sueño/tratamiento farmacológico , Adolescente , Adulto , Anciano , Niño , Preescolar , Utilización de Medicamentos , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Taiwán
14.
Transplant Proc ; 40(8): 2852-3, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18929883

RESUMEN

Aortic root aneurysm after orthotopic heart transplantation (HTx) is rare. It may originate from cystic medial necrosis of the donor heart aorta. Herein we have reported a 64-year-old man who received an orthotopic HTx due to dilated cardiomyopathy. Although asymptomatic, follow-up echocardiography revealed dilatation of the aortic root and severe aortic regurgitation at 3 years after the transplantation. He underwent a Bentall procedure with a prosthetic valved conduit. The post-operative course was uneventful. This case demonstrated that a heart-transplant recipient with a late aortic root aneurysm can be successfully treated with an excellent outcome.


Asunto(s)
Aneurisma de la Aorta Torácica/cirugía , Cardiomiopatía Dilatada/cirugía , Trasplante de Corazón/métodos , Complicaciones Posoperatorias/cirugía , Adulto , Cardiomiopatía Dilatada/diagnóstico por imagen , Ecocardiografía , Implantación de Prótesis de Válvulas Cardíacas , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/diagnóstico por imagen , Donantes de Tejidos , Resultado del Tratamiento
15.
J Phys Chem A ; 111(47): 11948-60, 2007 Nov 29.
Artículo en Inglés | MEDLINE | ID: mdl-17985850

RESUMEN

Femtosecond time-resolved photoelectron spectroscopy and high-level theoretical calculations were used to study the effects of methyl substitution on the electronic dynamics of the alpha,beta-enones acrolein (2-propenal), crotonaldehyde (2-butenal), methylvinylketone (3-buten-2-one), and methacrolein (2-methyl-2-propenal) following excitation to the S2(pipi*) state at 209 and 200 nm. We determine that following excitation the molecules move rapidly away from the Franck-Condon region, reaching a conical intersection promoting relaxation to the S1(npi*) state. Once on the S1 surface, the trajectories access another conical intersection, leading them to the ground state. Only small variations between molecules are seen in their S2 decay times. However, the position of methyl group substitution greatly affects the relaxation rate from the S1 surface and the branching ratios to the products. Ab initio calculations used to compare the geometries, energies, and topographies of the S1/S0 conical intersections of the molecules are not able to satisfactorily explain the variations in relaxation behavior. We propose that the S1 lifetime differences are caused by specific dynamical factors that affect the efficiency of passage through the S1/S0 conical intersection.

16.
Br J Dermatol ; 155(6): 1201-8, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17107390

RESUMEN

BACKGROUND: Primary cutaneous amyloidosis (PCA) is a relatively common skin disorder in South America and Southeast Asia. Most cases of PCA are sporadic but familial aggregation has been reported from South America and Taiwan. The different susceptibility among ethnic groups suggests that genetic factors may play an important role in its pathogenesis. OBJECTIVES: We aimed to perform a genome-wide scan by linkage analysis across 15 families with familial primary cutaneous amyloidosis (FPCA) to map the disease gene(s) for FPCA. PATIENTS AND METHODS: A total of 15 FPCA families including 50 individuals affected with PCA were recruited. Throughout the 22 autosomes, 369 polymorphic microsatellite markers were used initially. Regions showing a LOD score > 1 identified in the initial scan were further analysed with additional markers. Two-point and multipoint linkage analysis were performed by using the LINKAGE program. Nonparametric linkage (NPL) analysis and reconstruction of haplotypes were performed with the GENEHUNTER program. RESULTS: A maximum two-point LOD score of 4.76 for the marker D5S1490 (theta = 0.10, alpha = 0.60) and a multipoint LOD score of 4.50 between D5S822 and D5S623 (alpha = 0.60) were obtained under the assumption of heterogeneity. A peak NPL score of 5.23 (P value = 0.000007) was found from D5S1490 to D5S2076. Further analysis focusing on two major families identifies a common haplotype shared by all affected individuals between D5S1490 and D5S623. To our knowledge, this is the first report of genome-wide analysis of a large number of FPCA pedigrees. CONCLUSIONS: Our study provides evidence for significant linkage to chromosome 5p13.1-q11.2 in a subset of FPCA families.


Asunto(s)
Amiloidosis/genética , Cromosomas Humanos Par 5/genética , Predisposición Genética a la Enfermedad , Enfermedades de la Piel/genética , Adolescente , Adulto , Pueblo Asiatico/genética , Niño , Familia , Femenino , Ligamiento Genético , Marcadores Genéticos , Genotipo , Humanos , Escala de Lod , Masculino , Repeticiones de Microsatélite , Persona de Mediana Edad , Linaje
17.
Arch Androl ; 52(5): 371-4, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16873137

RESUMEN

This study was conducted to compare pregnancy rates following two different timings of intrauterine insemination (IUI) in ovarian stimulated cycles. This retrospective study included 135 couples undergoing treatment for infertility. IUI was performed at either 24 hr or 36 hr after hCG injection. Pregnancy rates did not differ between the two groups or in subgroups receiving different methods of ovarian stimulation. Pregnancy rates were similar when IUI was performed at either 24 or 36 hr after hCG injection in ovarian stimulated cycles.


Asunto(s)
Inseminación Artificial , Inducción de la Ovulación , Adulto , Femenino , Humanos , Embarazo
18.
Clin Microbiol Infect ; 12(8): 806-9, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16842580

RESUMEN

A cloned 5,248-bp EcoRI fragment from the Klebsiella pneumoniae transferable plasmid pKP53 (> 70 kb) containing bla(SHV-5) was sequenced. Insertion sequences IS26 and IS5 were found downstream from bla(SHV-5). The DNA sequences of the genetic environment surrounding bla(SHV-5) were homologous to plasmid p1658/97 from Escherichia coli, containing a truncated recF gene and a truncated deoR gene upstream and downstream from bla(SHV-5), respectively. RecF may be involved in bla(SHV-5) translocation to the plasmid by RecF-dependent recombination. This novel genetic environment may be associated with the successful proliferation and/or expression of SHV-5 in K. pneumoniae strains from Taiwan.


Asunto(s)
Elementos Transponibles de ADN , Klebsiella pneumoniae/genética , beta-Lactamasas/genética , Secuencia de Bases , Klebsiella pneumoniae/enzimología , Datos de Secuencia Molecular , Plásmidos , Análisis de Secuencia de ADN
19.
J Phys Chem B ; 110(26): 12938-42, 2006 Jul 06.
Artículo en Inglés | MEDLINE | ID: mdl-16805595

RESUMEN

Electrochemical oxidation and reduction were utilized to modify vertically aligned carbon nanotube (CNT) arrays grown on a porous network of conductive carbon microfibers. Ultrafast and complete CNT opening and purification were achieved through electrochemical oxidation. Highly dispersed platinum nanoparticles were then uniformly and densely deposited as electrocatalysts onto the surface of these CNTs through electrochemical reduction. Using supercritical drying techniques, we demonstrate that the unidirectionally aligned and laterally spaced geometry of the CNT arrays can be fully retained after being subjected to each step of electrochemical modification. The open-tipped CNTs can also be electrochemically detached in full lengths from the supporting substrates and harvested if needed.

20.
J Neural Transm (Vienna) ; 113(10): 1425-33, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16604306

RESUMEN

Increased alpha-synuclein expression may be involved in the pathogenesis of Parkinson's disease (PD). We investigated the association of Rep1 microsatellite and RsaI T-to-C substitution in the alpha-synuclein promoter region with the risk of PD by a case-control study. The RsaI C/C genotype and C allele were found less frequently in PD patients than in controls. A reduced risk of the Rep1-RsaI 0-C haplotype (OR = 0.57, 95% CI = 0.36-0.90) with PD was evident. The quantitative real-time PCR study showed that the alpha-synuclein mRNA expression was increased (although not significantly) in PD patients with RsaI T/T genotype or Rep1-RsaI 0-T haplotype as compared to T/C genotype or 0-C haplotype. Reporter constructs containing the RsaI C allele drove significantly lower transcriptional activity compared with the RsaI T allele in both IMR32 and 293 cells. The findings suggest that the RsaI T-to-C substitution may have a functional relevance to the susceptibility to PD.


Asunto(s)
Predisposición Genética a la Enfermedad , Enfermedad de Parkinson/genética , Polimorfismo Genético , Regiones Promotoras Genéticas/genética , alfa-Sinucleína/genética , Adulto , Anciano , Anciano de 80 o más Años , Alelos , Femenino , Genotipo , Haplotipos , Humanos , Masculino , Repeticiones de Microsatélite , Persona de Mediana Edad , ARN Mensajero/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA